Trialect

Verified

Edward N. and Della L. Thome Memorial Foundation Awards Program in Alzheimers Disease Drug Discovery Research

Medical Foundation, a Division of Health Resources in Action

The goal of the Thome Memorial Foundation Awards Program in Alzheimer’s Disease Drug Discovery Research is to support innovative preclinical and translational drug discovery research that will lead to improved therapies for all individuals suffering from Alzheimer’s disease.

In 2026, an estimated 7.2 million people aged 65 and older are living with clinical Alzheimer’s disease (AD) dementia in the U.S. Given the tremendous societal impact and limited treatments currently available, there is a great need to better understand the biological drivers of disease risk and progression, which can then inform the development of novel therapeutics.

Among the millions of people living with AD, certain populations experience a greater disease burden compared to others. For instance, twice as many women are diagnosed with AD than men. Black Americans and Hispanic Americans are at higher risk for developing Alzheimer’s disease and other dementias compared to White Americans (2x and 1.5x greater risk, respectively). The Thome Memorial Foundation aims to advance innovative preclinical and translational drug development research that will benefit all people with AD, especially those populations that experience a particularly high disease burden and/or are historically understudied .

Two award types will be offered:

Postdoctoral Research Fellowship Award : Up to $125,000 over two years. Eligible applicants include senior postdoctoral researchers and mentored clinician scientists.
Early Career Investigator Award : Up to $275,000 over two years. Applicants must be full-time tenure-track or clinician-scientist/investigator track research faculty who have received or will receive their first independent research faculty appointment on or between June 1, 2024 through June 1, 2027.

Deadline: Oct. 13, 2026

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: Medical Foundation, a Division of Health Resources in Action

Sponsor Type:

Address: NA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity